137 related articles for article (PubMed ID: 32882784)
1. Should we prescribe montelukast to allergic pediatric patients?
Park YM
Clin Exp Pediatr; 2020 Oct; 63(10):389-390. PubMed ID: 32882784
[No Abstract] [Full Text] [Related]
2. Montelukast in general pediatric practices.
Ngamphaiboon J
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S348-51. PubMed ID: 16623053
[TBL] [Abstract][Full Text] [Related]
3. Healthcare utilisation and costs associated with adding montelukast to current therapy in patients with mild to moderate asthma and co-morbid allergic rhinitis: PRAACTICAL study.
Dal Negro R; Piskorz P; Vives R; Guilera M; Sazonov Kocevar V; Badia X
Pharmacoeconomics; 2007; 25(8):665-76. PubMed ID: 17640108
[TBL] [Abstract][Full Text] [Related]
4. A Randomized, Multicenter, Double-blind, Phase III Study to Evaluate the Efficacy on Allergic Rhinitis and Safety of a Combination Therapy of Montelukast and Levocetirizine in Patients With Asthma and Allergic Rhinitis.
Kim MK; Lee SY; Park HS; Yoon HJ; Kim SH; Cho YJ; Yoo KH; Lee SK; Kim HK; Park JW; Park HW; Chung JH; Choi BW; Lee BJ; Chang YS; Jo EJ; Lee SY; Cho YS; Jee YK; Lee JM; Jung J; Park CS
Clin Ther; 2018 Jul; 40(7):1096-1107.e1. PubMed ID: 29945738
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
Bisgaard H; Skoner D; Boza ML; Tozzi CA; Newcomb K; Reiss TF; Knorr B; Noonan G
Pediatr Pulmonol; 2009 Jun; 44(6):568-79. PubMed ID: 19449366
[TBL] [Abstract][Full Text] [Related]
6. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.
Philip G; Nayak AS; Berger WE; Leynadier F; Vrijens F; Dass SB; Reiss TF
Curr Med Res Opin; 2004 Oct; 20(10):1549-58. PubMed ID: 15462688
[TBL] [Abstract][Full Text] [Related]
7. Montelukast in the treatment of allergic rhinitis: an evidence-based review.
Nayak A; Langdon RB
Drugs; 2007; 67(6):887-901. PubMed ID: 17428106
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
9. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
[TBL] [Abstract][Full Text] [Related]
10. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.
Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):767-74. PubMed ID: 17201236
[TBL] [Abstract][Full Text] [Related]
11. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Clin Exp Allergy; 2001 Apr; 31(4):616-24. PubMed ID: 11359431
[TBL] [Abstract][Full Text] [Related]
12. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
14. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy.
Sazonov-Kocevar V; Laforest L; Travier N; Yin DD; Van Ganse E
Pediatr Allergy Immunol; 2006 Dec; 17(8):620-8. PubMed ID: 17121591
[TBL] [Abstract][Full Text] [Related]
15. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
Lehtimäki L; Petäys T; Haahtela T
Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
[TBL] [Abstract][Full Text] [Related]
16. The effect of montelukast sodium on serum arginase levels in patients with seasonal allergic rhinitis.
Yasar H; Kiran B; Cagatay T; Ozkul H; Icten S
Am J Rhinol Allergy; 2011; 25(4):e153-5. PubMed ID: 21439134
[TBL] [Abstract][Full Text] [Related]
17. Montelukast decreased exhaled nitric oxide in children with perennial allergic rhinitis.
Hung CH; Hua YM; Hsu WT; Lai YS; Yang KD; Jong YJ; Chu YT
Pediatr Int; 2007 Jun; 49(3):322-7. PubMed ID: 17532829
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis.
Scaife A; Miller D; Spiteri-Cornish D; Turner SW; Devereux GS; Walsh GM
Respir Med; 2013 Dec; 107(12):1859-65. PubMed ID: 24080250
[TBL] [Abstract][Full Text] [Related]
19. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of montelukast in pediatric patients with allergic rhinitis.
Yilmaz O; Altintas D; Rondon C; Cingi C; Oghan F
Int J Pediatr Otorhinolaryngol; 2013 Dec; 77(12):1922-4. PubMed ID: 24210867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
